Ulcerative Colitis Clinical Research Trials

Birmingham : University of Alabama at Birmingham

An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

Birmingham : University of Alabama at Birmingham

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Dothan : Digestive Health Specialists of the Southeast

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Mobile : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Mobile : Horizon Research Group, Inc.

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Mobile : Internal Medicine Center, LLC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Mobile : Springhill Memorial Hospital

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Mobile :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Phoenix :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Scottsdale : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Sun City : Investigational Site Number 840065

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Tucson : Adobe Surgery Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Tucson : Adobe Clinical Research, LLC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Little Rock : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Little Rock : Arkansas Children's Hospital

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Los Angeles : Gastrointestinal Bioscience

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Los Angeles : Cedars-Sinai Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Montebello : Paramount Medical Specialty

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Sacramento : Capital Gastroenterology Consultants Medical Group

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

San Diego : Desta Digestive Disease Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

San Diego : Clinical Applications Laboratories Inc.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Anaheim : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Anaheim :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Anaheim : Anaheim Clinical Trials

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Anaheim : Santarus Clinical Investigational Site 1043 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Anaheim : Advanced Clinical Research Institute

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Francisco :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Glendale : Research Site

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Glendale : Research Site

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

La Jolla : UCSD Medical Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

La Jolla : UCSD Medical Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Lakewood : Santarus Clinical Investigational Site 1071 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Los Angeles : Cedars Sinai Medical Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Los Angeles : Cedars-Sinai Medical Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Los Angeles : Investigational Site Number 840031

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Los Angeles : Cedars Sinai Medical Center

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Los Angeles : Cedars-Sinai Medical Center

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Los Angeles : Cedars-Sinai Medical Center - Inflammatory Bowel Disease Center

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Los Angeles : Santarus Clinical Investigational Site 1051 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Los Angeles :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Mission Hills : Investigational Site Number 840059

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Oakland :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Palm Springs : Homan A Zadeh, MD, MPH

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Palm Springs : Homan A Zadeh, MD, MPH

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Rancho Mirage : Hope Square Surgical Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

San Diego : Sharp Rees-Stealy Medical Group

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

San Diego : Clinical Application Laboratories, Inc.

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

San Diego : San Diego Endoscopy Center

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

San Diego : Investigational Site Number 840074

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

San Diego : Sharp Rees-Stealy Medical Group

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

San Diego : Santarus Clinical Investigational Site 1003 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

San Diego : Santarus Clinical Investigational Site 1053 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

San Diego :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

San Francisco : University of California, San Francisco

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Aurora : University of CO Health Sciences Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lafayette : Gastroenterology of the Rockies

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lakewood : Rocky Mountain Gastroenterology Associates P.L.L.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Littleton : Arapahoe Gastroenterology Associates P.C

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lone Tree : South Denver Gastroenterology

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Pueblo : Lynn Institute of Pueblo

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Denver :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Lakewood : Rocky Mountain Gastroenterology

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Lakewood, : Investigational Site Number 840030

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Littleton : Investigational Site Number 840061

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Littleton : Santarus Clinical Investigational Site 1063 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Hamden : Gastroenterology Center of Connecticut, P.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Bristol : Santarus Clinical Investigational Site 1028 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Giolford : Endoscopy Center of Connecticut, LLC

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Guilford : Endoscopy Center of Connecticut, LLC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Guilford : Endoscopy Center of Connecticut, LLC

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Hamden : Gastroenterology Center of Connecticut, PC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Hamden : Endoscopy Center of Connecticut, LLC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Hamden : Medical Research Center of Connecticut, LLC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Hamden : Endoscopy Center of Connecticut, LLC

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Hamden : Gastroenterology Center of Connecticut, PC

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Hamden : Medical Research Center of Connecticut, LLC

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Hamden : Pfizer Investigational Site

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Hamden : Endoscopy Center of Connecticut, LLC

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Hamden : Gastroenterology Center of Connecticut, LLC

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Hamden : Medical Research Center of Connecticut, LLC

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Hamden : Santarus Clinical Investigational Site 1018 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Hartford : Connecticut Children's Medical Center

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Hartford :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

New Haven :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Gainesville : University of Florida

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Jacksonville : Borland-Groover Clinic

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Jacksonville : University of Florida, Jacksonville

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Jacksonville : East Coast Institute for Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Melbourne : Osler Clinical Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Miami : University of Miami Miller School of Medicine

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

New Smyrna Beach : United Medical Research Institute

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Orlando : Internal Medicine Specialists

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Orlando : Compass Research LLC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Palm Harbor : Advanced Gastroenterology Associates

Ulcerative Colitis

Port Orange : Accord Clinical Research, LLC

Ulcerative Colitis

Tampa : University of South Florida

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Tampa : West Wind'r Research & Development, LLC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Winter Park : Shafran Gastroenterology Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Boynton : Santarus Clinical Investigational Site 1035 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Boynton Beach : Investigational Site Number 840054

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Clearwater : Investigational Site Number 840050

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Cooper City : South Broway Ebdiscopy

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Crystal River : Pfizer Investigational Site

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Dundin : North Pinellas Surgery Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Gainesville :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Hialeah : Pfizer Investigational Site

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Hialeah : Digestive Medical Associates

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Hollywood : Southern Clinical Research Consultants

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Inverness : Pfizer Investigational Site

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Jacksonville : Santarus Clinical Investigational Site 1045 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Largo : Santarus Clinical Investigational Site 1001 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Maitland : Center for Advanced Gastroenterology

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Maitland : MNH Surgical Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Maitland : Investigational Site Number 840041

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Maitland : Santarus Clinical Investigational Site 1024 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Miami : Jackson Memorial Hospital

Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease

Miami :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Miami : Research Site

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Miramar : Santarus Clinical Investigational Site 1013 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Miramar, : Investigational Site Number 840008

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Naples : Gastroenterology Group of Naples

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Naples : Gastroenterology Group of Naples

Dose Escalation and Remission (DEAR)

Naples : Investigational Site Number 840044

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Orlando : Internal Medicine Specialists

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Orlando : Citrus Ambulatory Surgery Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Orlando : Pfizer Investigational Site

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Palm Harbor : Advanced Gastroenterology Associates, LLC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Palm Harbor : West Coast Radiology

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Palm Harbor : Advanced Gastroenterology Associates

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Port Orange : Santarus Clinical Investigational Site 1029 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Tampa : West Wind'r Research & Development, LLC

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Winter Park : Shafran Gastroenterology Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Winter Park : Shafran Gastroenterology Center

Dose Escalation and Remission (DEAR)

Winter Park : Santarus Clinical Investigational Site 1010 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Winter Park : Shafran Gastroenterology

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Winter Park, : Investigational Site Number 840048

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Zephyrhills : Florida Medical Clinic

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Zephyrhills : Florida Medical Clinic

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Zephyrhills : Florida Medical Clinic

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Zephyrhills : Santarus Clinical Investigational Site 1002 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Atlanta : Atlanta Gastroenterology Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Decatur : Atlanta Center for Gastroenterology, P.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Macon : Gastroenterology Associates of Central Georgia

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Newnan : Digestive Research Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Savannah : St. Joseph's/Candler Health System

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Snellville : DLW Research System

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Agusta : Investigational Site Number 840073

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Alpharetta : Georgia Endoscopy Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Alpharetta : Georgia Endoscopy Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Alpharetta : Georgia Endoscopy Center

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Athens : Tri-County Research

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Atlanta : GI Consultants

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Atlanta : GI Consultants

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Atlanta : Atlanta Gastroenterology Associates

Dose Escalation and Remission (DEAR)

Atlanta :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Atlanta : GI Consultants

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Atlanta :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Atlanta :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Decatur : Atlanta Center for Gastroenterology, P.C.

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Decatur : Santarus Clinical Investigational Site 1050 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Decatur : The Atlanta Center for Gastroenterology

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Johns Creek : Emory Healthcare Heart Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Johns Creek : Emory Healthcare Heart Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Johns Creek : Emory Healthcare Heart Center

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Macon : Gastroenterology Associates of Central Georgia, LLC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Macon : Gastroenterology Associates of Central Georgia, LLC

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Macon : Gastroenterology Associates of Central Georgia, LLC

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Marietta : Santarus Clinical Investigational Site 1085 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Savannah, : Investigational Site Number 840053

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Suwanee : Atlanta Gastroenterology Associates

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Suwanee : Johns Creek Diagnostic Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Suwanee : Atlanta Gastroenterology Associates

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Suwanee : Johns Creek Diagnostic Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Suwanee : Pfizer Investigational Site

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Suwanee : Atlanta Gastroenterology Associates

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Boise :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Chicago : Rush University Medical Center - Treatment Research Center

Dysbiosis in inflammatory bowel disease.

Urbana : Carle Clinic Association P.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Arlington Heights : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Arlington Heights : NCH Medical Group

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Chicago : Investigational Site Number 840001

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Chicago : Santarus Clinical Investigational Site 1075 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Chicago :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Oak Lawn : Southwest Gastroenterology

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Oak Lawn : Investigational Site Number 840005

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Oak Lawn : Santarus Clinical Investigational Site 1065 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Indianapolis : Santarus Clinical Investigational Site 1058 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Clive : Iowa Digestive Disease Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Clive : Digestive & Liver Consultants

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Clive : Santarus Clinical Investigational Site 1008 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Davenport : Gastrointestinal Clinic of Quad Cities

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Kansas City : University Of Kansas

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Topeka : Cotton O'Neil Digestive Health Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Topeka : Cotton-O'Neil Clinical Research Center, Digestive Health

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Wichita : Professional Research Network of Kansas

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Lexington : University of Kentucky Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Louisville : University Of Louisville

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Baton Rouge : Gastroenterology Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Hammond : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Hammond : Investigational Site Number 840078

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Metairie : Santarus Clinical Investigational Site 1034 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

New Orleans :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Shreveport : Santarus Clinical Investigational Site 1032 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Portland :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Baltimore : University of Maryland Medical Group

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Chevy Chase : Metropolitan Gastroenterology Group, P.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Chevy Chase : Metropolitan Gastroenterology Group, PC Chevy Chase Clinical Research

Ulcerative Colitis and Crohn’s Disease (IBD) Research Study

Prince Frederick : Shah Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Annapolis : Santarus Clinical Investigational Site 1044 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Baltimore : University of Maryland Medical Center

Dose Escalation and Remission (DEAR)

Chevy Chase : Metropolitan Gastroenterology Group, PC - Chevy Chase Clinical Research

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Chevy Chase : Chevy Chase Clinical Research

Dose Escalation and Remission (DEAR)

Chevy Chase :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Chevy Chase : Chevy Chase Clinical Research

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Chevy Chase : Santarus Clinical Investigational Site 1057 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Hollywood : Investigational Site Number 840049

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Hollywood : Santarus Clinical Investigational Site 1012 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Prince Frederick : Shah Associates, MD, LLC

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Boston : Boston Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Boston : Massachusetts General Hospital

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Boston :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Worcester :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Dearborn : The Center for Clinical Studies

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Troy : Center for Digestive Health

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Wyoming : Gastroenterology Associates of Western Michigan, P.L.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Ann Arbor : University of Michigan Health Systems - A. Alfred Taubman Health Care Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Ann Arbor : University of Michigan Health Systems - A. Alfred Taubman Health Care Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Ann Arbor :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Berkley : Dr. Jason Bozdin, M.D.

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Chesterfield : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Chesterfield : Clinical Research Institute of Michigan, LLC

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Chesterfield : Clinical Research Institute of Michigan, LLC

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Chesterfield : Clinical Research Institute of Michigan

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Chesterfield : Santarus Clinical Investigational Site 1016 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Detroit :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Novi : Santarus Clinical Investigational Site 1081 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Troy : Center for Digestive Health

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Troy : Center for Digestive Health

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Troy : Center for Digestive Health

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Utica : Utica Surgery Center (Endoscopy ONLY)

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Wyoming : Investigational Site Number 840011

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Wyoming : Santarus Clinical Investigational Site 1015 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Wyoming : Gregory Cammel, MD PLC

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Ypsilanti : Santarus Clinical Investigational Site 1068 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Plymouth : Minnesota Gastroenterology, P.A.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Rochester : Mayo Clinic

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Minneapolis :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Plymouth : Minnesota Gastroenterology, P.A.

Dose Escalation and Remission (DEAR)

Rochester : Mayo Clinic

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Rochester : Mayo Clinic

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Rochester : Santarus Clinical Investigational Site 1074 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Rochester : Mayo Clinic

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Rochester :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Rochester :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Saint Paul :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Jackson : GI Associates and Endoscopy Center

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Ocean Springs : Investigational Site Number 840060

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Kansas City : Truman Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Mexico : Center for Digestive and Liver Diseases, Inc.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

St. Louis : Washington University

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

St. Louis : St. Louis Center for Clinical Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Columbia : Surgery Center of Columbia

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Hannibal : Hannibal Regional Hospital

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Mexico : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Mexico : Center for Digestive & Liver Disease, Inc.

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Mexico : Audrain Medical Center

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Mexico : Investigational Site Number 840024

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Mexico : Center for Digestive and Liver Disease

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Boys Town :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Lebanon : Dartmouth-Hitchcock Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lebanon : Santarus Clinical Investigational Site 1061 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Manchester :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Morristown : Affiliates in Gastroenterology PA

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

New Brunswick : University of Medicine and Dentistry of New Jersey-NJMS

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Vineland : The Gastroenterology Group of South Jersey

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Egg Harbour Township : AGA Clinical Research Associates, LLC

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Marlton : South Jersey Gastroenterology

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Marlton : South Jersey Gastroenterology

Dose Escalation and Remission (DEAR)

Mays Landing :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Morristown :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Vineland : The Gastroenterology Group of South Jersey

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Vineland : The Gastroenterology Group of South Jersey

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Vineland : The Gastroenterology Group of South Jersey

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Bayside : Hepatobiliary Associates of New York

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Cheektowaga : Digestive Health Physician

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Great Neck : Long Island Clinical Research Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Merrick : Long Island Gastroenterology Group, P.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

New York : The Rockefeller University Hospital

Inflammatory Bowel Disease Exacerbation and Changes in Gut Microbiome and Innate Immunity

New York : Present Chapman Marion Steinlauf MD PC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

New York : New York Presbyterian Hospital

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Pittsford : Kim, Chung MD (Private Practice)

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Rochester : University of Rochester

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Setauket : Long Island Digestive Disease Consultants

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Stonybrook : SUNY Stony Brook University Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Syracuse : Syracuse Gastroenterological Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Brooklyn :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Buffalo :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Cheektowaga : Santarus Clinical Investigational Site 1021 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Great Neck : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Great Neck : Long Island Clinical Research Associates, LLP

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Great Neck : Nassau Gastroenterology Associates, PC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Great Neck : Nassau Gastroenterology Associates

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Great Neck : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Great Neck : Investigational Site Number 840051

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Great Neck :

Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Great Neck : Santarus Clinical Investigational Site 1027 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Great Neck : Santarus Clinical Investigational Site 1072 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Great Neck : Long Island Clinical Research Associates, LLP

Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis

Great Neck : Long Island Clinical Research Associates

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Great Neck :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Lake Success : Santarus Clinical Investigational Site 1067 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Mineola :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

New Hyde Park :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

New York : Santarus Clinical Investigational Site 1031 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

New York : Research Associates of New York

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

New York :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Stony Brook :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Syracuse :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Chapel Hill : University of North Carolina at Chapel Hill

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Charlotte : Charlotte Gastroentology and Hepatology, P.L.L.C

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Elkin : Northwest Piedmont Clinical Research, Inc.

An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

Elkin : Northwest Piedmont Clinical Research, Inc.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Morganton : Burke Research Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Raleigh : Multi-Specialty Research Associates of NC

Do you have ulcerative colitis in remission?

Raleigh : Wake Research Associates

Struggling with Ulcerative Colitis?

Chapel Hill :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Davidson : Carolina Digestive Health Associates

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Durham :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Greensboro : LeBauer Endoscopy Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Greensboro : LeBauer HealthCare

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Greensboro : LeBauer Research Associates, P.A.

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Greenville : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Greenville : Carolina Research - Carolina Digestive Diseases

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Jacksonville, : Investigational Site Number 840018

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Wilmington : Santarus Clinical Investigational Site 1073 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Cincinnati : Consultants for Clinical Research Inc.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Dayton : Dayton Science Institute

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Cincinati : Santarus Clinical Investigational Site 1080 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Cincinnati : Investigational Site Number 840046

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Cincinnati :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Cincinnati :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Cleveland : Santarus Clinical Investigational Site 1078 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Columbus : Investigational Site Number 840006

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Columbus : Remington-Davis, Inc.

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Dayton : Santarus Clinical Investigational Site 1082 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Mentor : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Mentor : Great Lakes Gastroenterology

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Mentor : Great Lakes Gastroenterology

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Mentor : Great Lakes Gastroenterology

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Tulsa : Options Health Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Norman : Central Sooner Research

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Oklahoma City : Oklahoma Foundation for Digestive Research

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Oklahoma City :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Tulsa : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Tulsa : Gastroenterology United Tulsa

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Tulsa : Options Health Research

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Portland : The Oregon Clinic-West Hills Gastroenterology

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Pittsburgh : University of Pittsburgh Medical Center - Cancer Centers

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Danville :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Lancaster : Regional Gastroenterology Associates of Lancaster, Ltd.

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Lancaster : Santarus Clinical Investigational Site 1064 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Philadelphia : University of Pennsylvania - Presbyterian Medical Center

Dose Escalation and Remission (DEAR)

Philadelphia : University of Pennsylvania

Study of Cimzia for the Treatment of Ulcerative Colitis

Philadelphia :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Phoenixville : Investigational Site Number 840045

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Sayre : Donald Guthrie Foundation for Education and Research

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Sayre : Investigational Site Number 840022

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Sayre : Santarus Clinical Investigational Site 1006 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Charleston : Medical University Of SC CAR

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Greenville :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Germantown : Gastroenterology Center of the MidSouth, PC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Nashville : Vanderbilt University Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Germantown : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Germantown : Memphis Gastroenterology Group

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Hermitage : Associates in Gastroenteroogy

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Hermitage : Hermitage Imaging

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Hermitage : Associated Endoscopy

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Knoxville :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Memphis :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Nashville : Inflammatory Bowel Disease Clinic c/o Divison of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, Vanderbilt University

Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use

Nashville : Nashville Medical Research Institute

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Austin : Austin Gastroenterology, PA

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Houston : Gastroenterology Consultants

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Houston : Jacon Medical Research Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Houston : Baylor College Of Medicine

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Houston : Bayou City Research, Ltd.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Pasadena : Digestive Health Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

San Antonio : Stone Oak Research Foundation

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Tyler : Digestive Health Specialists of Tyler

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Austin : Santarus Clinical Investigational Site 1059 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Dallas : Dallas VA Medical Center

Exacerbating Factors in Inflammatory Bowel Disease

Dallas : Dallas VA Medical Center

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Dallas :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Fort Worth :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Houston : Gastroenterology Consultants, P.A.

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Houston : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Houston : Santarus Clinical Investigational Site 1004 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Houston : Santarus Clinical Investigational Site 1019 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Houston : Santarus Clinical Investigational Site 1039 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Humble : Investigational Site Number 840072

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Pasadena : Pasadena Gastroenterology Associates, P.A. dba Digestive Health Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Pasadena : Santarus Clinical Investigational Site 1005 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Pasadena, : Investigational Site Number 840019

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

San Antonio : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

San Antonio : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Sugar Land : Investigational Site Number 840038

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

The Woodlands : Santarus Clinical Investigational Site 1048 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Tyler : Digestive Health Specialists of Tyler

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Tyler : Digestive Health Specialists of Tyler

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Tyler : Digestive Health Specialists of Tyler

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Sandy : Granite Peaks Gastroenterology

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lancaster : Santarus Clinical Investigational Site 1014 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Ogden : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Ogden : Santarus Clinical Investigational Site 1020 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Salt Lake City : Alpine Medical Group

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Salt Lake City : Wasatch Endoscopy Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Salt Lake City : Wasatch Clinical Research

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Salt Lake City : Alpine Medical Group

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Salt Lake City : Wasatch Clinical Research

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Salt Lake City : Wasatch Endoscopy Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

West Jordan : RGL Medical Services

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Burlington :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Charlottesville : University of Virginia Health System

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Chesapeake : Gastroenterology Associates of Tidewater

A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of XXXXXXXXX Induction Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis.

Fairfax : Gastroenterology Associates of Northern Virginia

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Norfolk : Digestive and Liver Disease Specialist Ltd

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Richmond : Hunter Holmes McGuire VA Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Charlottesville : Investigational Site Number 840068

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Charlottesville :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Chesapeake : Santarus Clinical Investigational Site 1038 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Christianburg : Santarus Clinical Investigational Site 1025 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Fairfax :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Norfolk :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Edmonds : Puget Sound Medical Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Seattle : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Seattle : University of Washington

Study of Cimzia for the Treatment of Ulcerative Colitis

Seattle :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Madison : Pharmaseek, LLC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Milwaukee : Wisconsin Center for Advanced Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Milwaukee : Medical College Of Wisconsin

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Madison : Santarus Clinical Investigational Site 1036 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Madison :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Milwaukee : Wisconsin Center for Advanced Research - GI Associates, LLC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Milwaukee : Center for Digestive Health

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Milwaukee : Wisconsin Center for Advanced Research - GI Associates, LLC

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Milwaukee : Center for Digestive Health

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Milwaukee : Wisconsin Center for Advanced Research

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Milwaukee :

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Wauwatosa : Investigational Site Number 840064

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Adelaide : Research Site

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Adelaide : Research Site

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Concord : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Fitzroy :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Garran :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Herston : Research Site

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Herston : Research Site

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Parkville :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Prahran : Research Site

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Prahran : Research Site

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Innsbruck : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Ried im Innkreis : Site Reference ID/Investigator# 66064

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

St Veit an der Glan : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

St. Poelten : Site Reference ID/Investigator# 66188

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Bonheiden : Site Reference ID/Investigator# 61091

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Bonheiden : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Brussels : Site Reference ID/Investigator# 61093

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Brussels : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Gent : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Ghent : Site Reference ID/Investigator# 61092

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Ghent : Site Reference ID/Investigator# 61089

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Kortrijk : Site Reference ID/Investigator# 63843

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Leuven : Site Reference ID/Investigator# 61096

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Leuven : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Leuven : Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Leuven : UZ Leuven

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Leuven : UZ Leuven

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Leuven : Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Leuven :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Leuven :

Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Leuven : UZ Leuven

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Leuven : Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

LiÃ¨ge : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Liege : Site Reference ID/Investigator# 61094

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Roeselare : Site Reference ID/Investigator# 61090

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Pleven : Santarus Clinical Investigational Site 4003 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Plovdiv : Santarus Clinical Investigational Site 4009 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Plovdiv : Santarus Clinical Investigational Site 4004 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Ruse : Santarus Clinical Investigational Site 4008 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Sofia :

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Sofia : Santarus Clinical Investigational Site 4005 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Sofia : Santarus Clinical Investigational Site 4001 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Sofia : Santarus Clinical Investigational Site 4002 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Sofia : Santarus Clinical Investigational Site 4010 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Sofia : Santarus Clinical Investigational Site 4011 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Sofia : Santarus Clinical Investigational Site 4007 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Calgary : Site Reference ID/Investigator# 61408

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Guelph : Site Reference ID/Investigator# 64422

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Halifax : Site Reference ID/Investigator# 61406

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Halifax : Santarus Clinical Investigational Site 2008 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Hamilton : Site Reference ID/Investigator# 61407

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

London : Site Reference ID/Investigator# 61405

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

London : Santarus Clinical Investigational Site 2005 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

London : Santarus Clinical Investigational Site 2004 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

London :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Montreal : Santarus Clinical Investigational Site 2009 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Quebec : Santarus Clinical Investigational Site 2006 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Saskatoon : Site Reference ID/Investigator# 61762

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Sherbrooke : Santarus Clinical Investigational Site 2001 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Toronto : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Toronto : Toronto Digestive Disease Associates

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Toronto :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Vancouver : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Vaughan : Santarus Clinical Investigational Site 2002 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Victoria : Site Reference ID/Investigator# 61409

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Winnipeg : Site Reference ID/Investigator# 61403

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Winnipeg : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Winnipeg : Santarus Clinical Investigational Site 2003 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Beijing :

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Chengdu :

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Guangzhou :

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Hefei :

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Shanghai :

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Wuhan :

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Xian :

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Zagreb :

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Hradec Kralove : Research Sites 402 and 404

A clinical research study for patients 18 or older with Ulcerative Colitis

Ostrava : Research Sites 406 and 407

A clinical research study for patients 18 or older with Ulcerative Colitis

Prague : Research Sites 405 and 409

A clinical research study for patients 18 or older with Ulcerative Colitis

Slany : Research Site 403

A clinical research study for patients 18 or older with Ulcerative Colitis

Tabor : Research Site 401

A clinical research study for patients 18 or older with Ulcerative Colitis

Hradec Kralove : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Hradec Kralove : Santarus Clinical Investigational Site 3006 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Hradec Kralove : Santarus Clinical Investigational Site 3001 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Hradec Kralove :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Labem : Santarus Clinical Investigational Site 3005 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Nachod :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Olomouc : Santarus Clinical Investigational Site 3003 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Ostrava - Poruba :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Prague : Santarus Clinical Investigational Site 3009 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Praha : Santarus Clinical Investigational Site 3007 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Praha : Santarus Clinical Investigational Site 3004 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Praha 4 : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Praha 7 : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Tabor : Santarus Clinical Investigational Site 3002 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Usti nad Labem : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Usti nad Orlici : Santarus Clinical Investigational Site 3010 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Valasske Mezirici : Santarus Clinical Investigational Site 3011 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Zlin :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Ã…rhus C : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Aalborg : Site Reference ID/Investigator# 61117

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Aalborg : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Aarhus :

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Allerod : Noreba

Trial on Profermin and Fresubin in Ulcerative Colitis

Copenhagen : Site Reference ID/Investigator# 61118

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Herlev : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Hvidovre : Site Reference ID/Investigator# 61119

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Hvidovre : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

KÃ¸ge : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Odense : Odense University Hospital

Adalimumab in the Treatment of Chronic Pouchitis

Odense C : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Odense C : Odense University Hospital

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Tallinn : ECG Unit, East Tallinn Central Hospital

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Tallinn : X-Ray Unit, East Tallin Central Hospital

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Tallinn : ECG Unit, East Tallinn Central Hospital

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Tallinn : X-Ray Unit, East Tallinn Central Hospital

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Tallinn : Santarus Clinical Investigational Site 8001 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Tallinn : Santarus Clinical Investigational Site 8002 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Tartu : Santarus Clinical Investigational Site 8003 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Lahti : Site Reference ID/Investigator# 63292

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Caen Cedex 14 : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Grenoble Cedex 09 : Site Reference ID/Investigator# 61055

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Lille : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Lille Cedex : Site Reference ID/Investigator# 61059

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Nantes Cedex : Site Reference ID/Investigator# 61056

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Nice Cedex 3 : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Paris cedex 12 : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Pessac Cedex : Site Reference ID/Investigator# 63463

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Pessac Cedex : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Reims : Site Reference ID/Investigator# 61057

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

St. Priest en Jarez : Site Reference ID/Investigator# 61063

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Toulouse Cedex 9 : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Vandoeuvre les Nancy : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Vandoeuvre les Nancy Cedex : Site Reference ID/Investigator# 63462

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Berlin : Research Site 501

A clinical research study for patients 18 or older with Ulcerative Colitis

Bottrop : Research Site 508

A clinical research study for patients 18 or older with Ulcerative Colitis

Freiburg : Research Site 509

A clinical research study for patients 18 or older with Ulcerative Colitis

Hannover : Research Site 504

A clinical research study for patients 18 or older with Ulcerative Colitis

Jena : Research Site 503

A clinical research study for patients 18 or older with Ulcerative Colitis

Muenster : Research Site 506

A clinical research study for patients 18 or older with Ulcerative Colitis

Regensburg : Research Site 507

A clinical research study for patients 18 or older with Ulcerative Colitis

Stade : Research Site 502

A clinical research study for patients 18 or older with Ulcerative Colitis

Ulm : Research Site 505

A clinical research study for patients 18 or older with Ulcerative Colitis

Berlin : Site Reference ID/Investigator# 61064

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Berlin : Charité Campus Benjamin Franklin, Medizinische Klinik I

Endomicroscopy in Ulcerative Colitis

Dachau : Site Reference ID/Investigator# 64222

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Erlangen : Department of Medicine I, University of Erlangen-Nuremberg

Endomicroscopy in IBD Patients

Hamburg : Site Reference ID/Investigator# 61069

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Hannover : Medizinishce Hochschule hannover

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Hannover :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Herne : Site Reference ID/Investigator# 61066

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Jena : Friedrich-Schiller-Universität Jena, Klinik für Innere Medizin II

Endomicroscopy in Ulcerative Colitis

Lübeck :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Mainz : Johannes Gutenberg-Universität Mainz, I. Med. Klinik und Poliklinik

Endomicroscopy in Ulcerative Colitis

Minden : Site Reference ID/Investigator# 61065

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Minden :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Muenster : Site Reference ID/Investigator# 61067

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Ulm : Universitaetsklinikum Ulm

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Ulm : Universitaetsklinikum Ulm

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

ULM :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Athens : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Haidari : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Heraklion : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Larissa : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Piraeus : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Bekescsaba : Research Site 205

A clinical research study for patients 18 or older with Ulcerative Colitis

Budapest : Research Sites 204 and 207

A clinical research study for patients 18 or older with Ulcerative Colitis

Kaposvar : Research Site 203

A clinical research study for patients 18 or older with Ulcerative Colitis

Szekszard : Research Site 202

A clinical research study for patients 18 or older with Ulcerative Colitis

Bekescsaba : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Bekescsaba : Santarus Clinical Investigational Site 5010 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Budapest : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Budapest : Santarus Clinical Investigational Site 5008 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Budapest : Santarus Clinical Investigational Site 5009 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Budapest :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Debrecen : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Debrecen : Santarus Clinical Investigational Site 5001 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

GYR :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Gyula :

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Gyula : Santarus Clinical Investigational Site 5003 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Kaposvar : Santarus Clinical Investigational Site 5004 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Miskolc : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Miskolc : Santarus Clinical Investigational Site 5002 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Mosonmagyarovar : Santarus Clinical Investigational Site 5006 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Pecs : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Pecs : Santarus Clinical Investigational Site 5011 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Szeged : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Szeged : Santarus Clinical Investigational Site 5005 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Szekszard : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Vac : Santarus Clinical Investigational Site 5007 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Dublin 24 : Site Reference ID/Investigator# 65987

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Dublin 4 : Site Reference ID/Investigator# 65988

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Dublin 9 : Site Reference ID/Investigator# 65989

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Be'er Sheva : Soroka Medical Center

Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis

Haifa : Rambam Medical Center

Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis

Haifa :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Jerusalem : Site Reference ID/Investigator# 64204

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Jerusalem : Shaare Zedek Medical center

Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis

Jerusalem : Hadassah medical center

Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis

Jerusalem :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Petach Tikva : Site Reference ID/Investigator# 64206

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Ramat-gan :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Tel Aviv : Sourasky Medical Center

Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis

Tel Aviv :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Tel Hashomer : Site Reference ID/Investigator# 64202

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Bologna : Research Site 301

A clinical research study for patients 18 or older with Ulcerative Colitis

Rome : Research Sites 302 and 304

A clinical research study for patients 18 or older with Ulcerative Colitis

Torino : Research Site 303

A clinical research study for patients 18 or older with Ulcerative Colitis

Bologna : Site Reference ID/Investigator# 61112

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Bologna : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Crema : Ospedale Maggiore di Crema, Endoscopy and Gastroenterology Division

Endomicroscopy in Ulcerative Colitis

Firenze : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Milano : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Milano : European Institute of Oncology, Division of Endoscopy

Endomicroscopy in Ulcerative Colitis

Padova : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Palermo : Site Reference ID/Investigator# 61108

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Roma : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Rome : Site Reference ID/Investigator# 61104

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Rome : Site Reference ID/Investigator# 61115

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Rozzano : Site Reference ID/Investigator# 61111

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Rozzano MI : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Chikushino : Fukuoka University Chikushi Hospital

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Chikushino : Fukuoka University Chikushi Hospital

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Hokkaido : Sapporo higashi tokushukai hospital

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Osaka : Osaka City University Hospital

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Sapporo : Hokkaido P.W.F.A.C Sapporo-Kosei general Hospital

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Sapporo : Hokkaido P.W.F.A.C Sapporo-Kosei general Hospital

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Sendai : National Hospital Organization Sendai Medical Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Sendai : National Hospital Organization Sendai Medical Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Takatsuki-shi : Osaka Medical College Hospital

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Takatsuki-shi : Osaka Medical College Hospital

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Riga : Santarus Clinical Investigational Site 8101 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Riga : Santarus Clinical Investigational Site 8103 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Riga : Santarus Clinical Investigational Site 8102 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Kaunas : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Kaunas : Santarus Clinical Investigational Site 8202 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Klaipeda : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Siauliai : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Vilnius : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Vilnius : Santarus Clinical Investigational Site 8203 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Vilnius : Santarus Clinical Investigational Site 8201 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Amsterdam : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Maastricht : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Auckland :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Christchurch :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Tauranga : Clinical Trials Unit, BOP Clinical School, Bay of Plenty District Health Board

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Tauranga : Clinical Trials Unit, BOP Clinical School, Bay of Plenty District Health Board

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Hamar : Site Reference ID/Investigator# 62364

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Oslo : Site Reference ID/Investigator# 62362

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Oslo : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

TromsÃ¸ : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Krakow : Research Site 604

A clinical research study for patients 18 or older with Ulcerative Colitis

Lodz : Research Site 605

A clinical research study for patients 18 or older with Ulcerative Colitis

Warszawa : Research Sites 601, 602, 603

A clinical research study for patients 18 or older with Ulcerative Colitis

Elblag : Santarus Clinical Investigational Site 6003 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Katowice :

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Krakow : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Krakow : Santarus Clinical Investigational Site 6001 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Lodz : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Lublin : Klinika Pediatrii Dzieciecy Szpital Kliniczny im prof Antoniego Gebali

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Rzeszow : Kliniczny Oddzial Pediatrii z Pododdzialem Neurologii Dzieciecej Szpital Wojewodzki

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Rzgowska : Klinika Gastroenterolofii Pediatrii, Instytut Centrum Zdrowia Matki Polki

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Sopot : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Sopot : Santarus Clinical Investigational Site 6002 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Szczecin : Santarus Clinical Investigational Site 6006 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Warszawa : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Warszawa : Santarus Clinical Investigational Site 6008 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Warszawa : Santarus Clinical Investigational Site 6004 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Warszawa : Oddzial Gastroenterologii i Hepatologii, Instytut Pomnik-Centrum Zdrowia Dziecka

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Warszawy : Santarus Clinical Investigational Site 6005 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Wieliczka : Klinika Pediatrii Gastroenterologii i Zywienia, Uniwersytecki Szpital Dzieciecy w Krakowie

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Wroclaw : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Faro : Site Reference ID/Investigator# 61100

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Lisbon : Site Reference ID/Investigator# 61101

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Porto : Site Reference ID/Investigator# 61098

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Ponce : Pharmaseek, LLC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Moscow :

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Moscow : Santarus Clinical Investigational Site 9010 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Moscow : Santarus Clinical Investigational Site 9005 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Nizhny Novgorod : Santarus Clinical Investigational Site 9004 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Ryazan : Santarus Clinical Investigational Site 9003 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Saint Petersburg : Santarus Clinical Investigational Site 9008 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Saratov : Santarus Clinical Investigational Site 9009 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

St Petersburg : Santarus Clinical Investigational Site 9001 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Stavropol : Santarus Clinical Investigational Site 9007 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Ufa : Santarus Clinical Investigational Site 9006 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Banska Bystrica : DFNsP Banska Bystrica

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Limbova 2 : Gastroenterologicka ambulancia

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Martin : Univerzitna nemocnica Martin

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Nitra : Jessenius - diagnosticke centrum a.s.

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Nitra : Kardiocentrum Nitra s.r.o.

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Nitra : KM Management spol. s.r.o.

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Nitra : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Nitra : Kardiocentrum Nitra s.r.o.

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Nitra : KM Management spol. s.r.o.

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Nitra : Jessenius - diagnosticke centrum a.s.

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Nove Mesto nad Vahom : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Badalona - Barcelona : Site Reference ID/Investigator# 61087

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Barcelona : Site Reference ID/Investigator# 61083

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Barcelona : Site Reference ID/Investigator# 61086

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Cordoba : Site Reference ID/Investigator# 61085

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Madrid : Site Reference ID/Investigator# 61082

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Madrid : Site Reference ID/Investigator# 63988

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Santiago de Compostela : Site Reference ID/Investigator# 61088

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Linkoping : Site Reference ID/Investigator# 61073

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Lund : Site Reference ID/Investigator# 61072

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Skovde : Site Reference ID/Investigator# 65583

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Stockholm : Site Reference ID/Investigator# 65586

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Stockholm : Södersjukhuset

A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis

Basel : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Bern : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

St. Gallen : Site Reference ID/Investigator# 66183

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Zurich : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Crimea : Santarus Clinical Investigational Site 7010 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Donetsk : Santarus Clinical Investigational Site 7002 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Kharkiv : Santarus Clinical Investigational Site 7004 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Kharkiv : Santarus Clinical Investigational Site 7001 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Kyiv : Santarus Clinical Investigational Site 7006 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Kyiv : Santarus Clinical Investigational Site 7008 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Odessa :

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Vinnytsia : Santarus Clinical Investigational Site 7005 Updated

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

London : Research Site 102

A clinical research study for patients 18 or older with Ulcerative Colitis

Norwich : Research Site 103

A clinical research study for patients 18 or older with Ulcerative Colitis

Nottingham : Research Site 101

A clinical research study for patients 18 or older with Ulcerative Colitis

Birmingham :

A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)

Birmingham : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Blackpool : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Coventry :

A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)

Gloucester : Site Reference ID/Investigator# 62367

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Liverpool :

A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)

Liverpool : Royal Liverpool University Hospital

Rituximab in Ulcerative Colitis

London : Site Reference ID/Investigator# 62567

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

London : Research Site Updated

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Newcastle Upon Tyne :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Oxford : Site Reference ID/Investigator# 61046

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Southampton : Site Reference ID/Investigator# 62568

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Wigan :

A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)

Worthing : Worthing Hospital

Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)

Ulcerative Colitis Clinical Trials

Alabama

Arizona

Arkansas

California

Colorado

Connecticut

Florida

Georgia

Idaho

Illinois

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Nebraska

New Hampshire

New Jersey

New York

North Carolina

Ohio

Oklahoma

Oregon

Pennsylvania

South Carolina

Tennessee

Texas

Utah

Vermont

Virginia

Washington

Wisconsin

Australia

Austria

Belgium

Bulgaria

Canada

China

Croatia

Czech Republic

Denmark

Estonia

Finland

France

Germany

Greece

Hungary

Ireland

Israel

Italy

Japan

Latvia

Lithuania

Netherlands

New Zealand

Norway

Poland

Portugal

Puerto Rico

Russian Federation

Slovakia

Spain

Sweden

Switzerland

Ukraine

United Kingdom